Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease

American Journal of Veterinary Research

Volumn 65, Issue 12, 2004, Pages 1644-1652

  Tarnow, Inge ^a   Kristensen, Annemarie T ^a   Olsen, Lisbeth H ^a   Pedersen, Henrik D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRINOGEN; POLYMER; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

AORTA ROOT; ARTICLE; BLOOD ANALYSIS; BLOOD CHEMISTRY; CONTROLLED STUDY; DISEASE SEVERITY; DOG; ECHOCARDIOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HEMOSTASIS; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; SHEAR STRESS; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

ANIMALS; BIOLOGICAL MARKERS; DOG DISEASES; DOGS; ELECTROCARDIOGRAPHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBRINOGEN; HEART VALVE DISEASES; HEMOSTASIS; MALE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; VON WILLEBRAND FACTOR;

ANIMALIA; CANIS FAMILIARIS;

EID: 11144268025     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1644     Document Type: Article

References (44)

1. Buchanan JW. Chronic valvular disease (endocardiosis) in dogs. Adv Vet Sci Comp Med 1997;21:75-106.
2. Beardow AW, Buchanan JW. Chronic mitral valve disease in Cavalier King Charles Spaniels: 95 cases (1987-1991). J Am Vet Med Assoc 1993;203:1023-1029.
3. Pedersen HD, Kristensen BO, Lorentzen KA, et al. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study. Can J Vet Res 1995;59:294-298.
4. Pedersen HD, Lorentzen KA, Kristensen BO. Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: epidemiology and prognostic significance for regurgitation. Vet Rec 1999;144:315-320.
5. Pedersen HD, Haggstrom J. Mitral valve prolapse in the dog: a model of mitral valve prolapse in man. Cardiovasc Res 2000; 47:234-243.
6. Darke PG. Valvular incompetence in cavalier King Charles spaniels. Vet Rec 1987;120:365-366.
7. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217:1500-1504.
8. Millis DL, Hauptmann JG, Fulton RB Jr. Abnormal hemostatic profiles and gastric necrosis in canine gastric dilatation-volvulus. Vet Surg 1993;22:93-97.
9. Hammer AS, Couto CG, Swardson C, et al. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med 1991;5:11-14.
10. Avierinos J-F, Brown RD, Foley DA, et al. Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors. Stroke 2003;34:1339-1345.
11. Goldsmith IR, Blann AD, Patel RL, et al. Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction. Heart 2000;83:577-578.
12. Pedersen HD, Schütt T, Söndergaard R, et al. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation. J Vet Intern Med 2003;17:178-184.
13. Blann AD. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993;50:125-134.
14. Schumacher A, Seljeflot I, Sommervoll L, et al. Increased levels of endothelial haemostatic markers in patients with coronary heart disease. Thromb Res 2002;105:25-31.
15. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003;89:601-609.
16. Lip GY. Fibrinogen and cardiovascular disorders. QJM 1995;88:155-165.
17. Matsuo T, Kobayashi H, Kario K, et al. Fibrin D-Dimer in thrombogenic disorders. Semin Thromb Hemost 2000;26:101-107.
18. Griffin A, Callan MB, Shofer FS, et al. Evaluation of a canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. Am J Vet Res 2003;64:1562-1569.
19. Nelson OL, Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med 2003; 17:830-834.
20. Eksell P, Haggstrom J, Kvart C, et al. Thrombocytopenia in the Cavalier King Charles Spaniel. J Small Anim Pract 1994;35:153-155.
21. Pedersen HD, Haggstrom J, Olsen LH, et al. Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an autosomal recessive trait. J Vet Intern Med 2002;16:169-173.
22. Olsen LH, Kristensen AT, Haggstrom J, et al. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse. J Vet Intern Med 2001;15:209-216.
23. Tanaka R, Yamane Y. Platelet aggregation in dogs with mitral valve regurgitation. Am J Vet Res 2000;61:1248-1251.
24. Tarnow I, Kristensen AT, Texel H, et al. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation. J Vet Intern Med 2003;17:680-686.
25. Kundu SK, Heilmann EJ, Sio ER, et al. Description of an in vitro platelet function analyzer-PFA100. Semin Thromb Hemost 1995;21:106-112.
26. Callan MB, Giger U. Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res 2001;62:652-658.
27. Johnstone IB. Multimeric analysis of von Willebrand factor in animal plasmas using sodium dodecyl sulfate agarose gel electrophoresis, semidry electrotransfer, and immunoperoxidase detection. J Vet Diagn Invest 1997;9:314-317.
28. Pedersen HD, Olsen LH, Mow T, et al. Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions. Res Vet Sci 1999;66:11-17.
29. Cornell CC, Kittleson MD, Della Torre P, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med 2004;18:311-321.
30. Lip GYH, Rumley A, Dunn FG, et al. Thrombogenesis in mitral regurgitation and aortic stenosis. Angiology 1996;47:1117-1124.
31. Madi AM, Greci LS, Nawaz H, et al. The activated partial thromboplastin time in early diagnosis of myocardial infarction. Blood Coagul Fibrinolysis 2001;12:495-499.
32. Galatius S, Wroblewski H, Sörensen VB, et al. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation. Am Heart J 1999;137:549-554.
33. Goldsmith IR, Blann AD, Patel RL, et al. Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation. Am J Cardiol 2000;86:234-236.
34. Gamba G, Venco A, Grandi A, et al. Mitral valve prolapse and factor VIII complex abnormalities. Haematologica 1984;69:551-555.
35. Pickering NJ, Brody JI, Barrett MJ. von Willebrand syndromes and mitral-valve prolapse; linked mesenchymal dysplasias. N Engl J Med 1981;305:131-134.
36. Froom P, Margulis T, Grenadier E, et al. von Willebrand factor and mitral valve prolapse. Thromb Haemost 1988;60:230-231.
37. Gill JC, Wilson AD, Endres-Brooks J, et al. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986;3:758-761.
38. Knecht M, Burkhoff D, Yi G-H, et al. Coronary endothelial dysfunction precedes heart failure and reduction of coronary reserve in awake dogs. J Mol Cell Cardiol 1997;29:217-227.
39. Martorana PA, Goebel B, Ruetten H, et al. Coronary endothelial dysfunction after ischemia and reperfusion in the dog: a functional and morphological investigation. Basic Res Cardiol 1998;93:257-263.
40. O'Brien JR, Tsai H-M, Etherington MD. Defective von Willebrand factor activity detected by the filterometer in three clinical conditions. Platelets 2000;11:388-394.
41. Vincentelli A, Susen S, Tourneau TL, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349:343-349.
42. Warkentin TE, Moore JC, Anand SS, et al. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 2003;17:272-286.
43. Tsai HM, Sussman II, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994;8:2171-2179.
44. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996;10:4235-4244.